NCT07018947
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07018947
Title Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC (ASPIRE)
Acronym ASPIRE
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fundacion Clinic per a la Recerca Biomédica
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Complejo Hospitalario Universitario de Santiago de Compostela Santiago de Compostela A Coruña 15706 Spain Details
Hospital Universitari Germans Trias i Pujol Badalona Barcelona 08916 Spain Details
Hospital Universitari de Bellvitge Barcelona Barcelona 08907 Spain Details
Hospital Universitari Vall d'Hebron Barcelona Barcelona Spain Details
Hospital Universitario Marqués de Valdecilla Santander Cantabria 39008 Spain Details
Hospital Universitario Reina Sofía Córdoba Cordoba 14004 Spain Details
Hospital Universitari Josep Trueta Girona Girona 17007 Spain Details
Hospital General Universitario Gregorio Marañón Madrid Madrid 28007 Spain Details
Hospital Universitario Ramón y Cajal Madrid Madrid 28034 Spain Details
Hospital Universitario Fundación Jiménez Díaz Madrid Madrid 28040 Spain Details
Hospital Universitario Virgen de la Victoria Puerto de la Torre Málaga 29010 Spain Details
Hospital Universitario y Politécnico La Fe Valencia Valencia 46026 Spain Details
Hospital Universitario de Cruces Barakaldo Vizcaya 48903 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field